Related Experiment Video
Updated: May 31, 2025

11:11
Efficient SARS-CoV-2 Quantitative Reverse Transcriptase PCR Saliva Diagnostic Strategy utilizing Open-Source Pipetting Robots
Published on: February 11, 2022
4.4K
Reusable Biosensor for Easy RNA Detection from Unfiltered Saliva
Paweł Wityk1,2,3, Agata Terebieniec4, Robert Nowak5,6
1Map Your DNA Ltd., Świerkowa 40, 83-330 Lniska, Poland.
Sensors (Basel, Switzerland)
|January 25, 2025
Summary
A new reusable biosensor detects SARS-CoV-2 RNA directly from saliva, bypassing filtration. This innovative device offers 100% accuracy for rapid COVID-19 diagnostics at the point-of-care.
Area of Science:
- Biomedical Engineering
- Molecular Diagnostics
- Sensor Technology
Background:
- Point-of-care diagnostics are crucial for rapid disease detection.
- Conventional methods for viral RNA detection often require complex sample preparation and filtration.
- There is a need for simplified, accurate, and reusable biosensors for direct sample analysis.
Purpose of the Study:
- To develop and validate a novel, reusable biosensor for direct detection of SARS-CoV-2 viral RNA from unfiltered saliva.
- To overcome limitations of existing methods by preventing interference from saliva debris.
- To provide a rapid, accurate, and cost-effective diagnostic tool for COVID-19.
Main Methods:
- Development of an electrochemical biosensor utilizing oligonucleotide probes immobilized on a hydrophobic-coated electrode.
- Design of a unique electrode to prevent interference from saliva debris and salt crystal formation.
- Validation of biosensor performance against RT-qPCR using clinical saliva samples from 60 participants.
Main Results:
- The biosensor achieved 100% sensitivity and 100% specificity in detecting SARS-CoV-2 RNA directly from saliva.
- No false positives or false negatives were observed during validation.
- Results showed perfect agreement with RT-qPCR, with 12 true positives and 48 true negatives identified.
Conclusions:
- The novel reusable biosensor enables direct, precise, and rapid detection of SARS-CoV-2 RNA from unfiltered saliva.
- This technology offers a significant advancement for point-of-care diagnostics, enhancing efficiency and cost-effectiveness.
- The biosensor's robust design and minimal sample preparation requirements make it suitable for diverse healthcare settings.

